Have a personal or library account? Click to login
Characteristics of COVID-19 Recurrence: A Systematic Review and Meta-Analysis Cover

Characteristics of COVID-19 Recurrence: A Systematic Review and Meta-Analysis

By: Tung Hoang  
Open Access
|Mar 2021

References

  1. 1Worldometer. COVID-19 coronavirus pandemic 2020. https://www.worldometers.info/coronavirus/.
  2. 2Sung HK, Kim JY, Heo J, et al. Clinical course and outcomes of 3,060 patients with coronavirus disease 2019 in Korea, January–May 2020. J Korean Med Sci. 2020; 35(30): e280.
  3. 3Yoneoka D, Kawashima T, Tanoue Y, et al. Early SNS-based monitoring system for the COVID-19 outbreak in Japan: A population-level observational study. J Epidemiol. 2020; 30(8): 36270. DOI: 10.2188/jea.JE20200150
  4. 4Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 170820. DOI: 10.1056/NEJMoa2002032
  5. 5Nandy K, Salunke A, Pathak SK, et al. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events. Diabetes Metab Syndr. 2020; 14(5): 101725. DOI: 10.1016/j.dsx.2020.06.064
  6. 6Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020; 52(2): 15464. DOI: 10.3947/ic.2020.52.2.154
  7. 7Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020. DOI: 10.1038/s10038-020-0808-9
  8. 8Hoang VT, Dao TL, Gautret P. Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19. J Med Virol. 2020; 92(11): 23667. DOI: 10.1002/jmv.26056
  9. 9Li N, Wang X, Lv T. Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon. J Med Virol. 2020; 92(11): 22867. DOI: 10.1002/jmv.25952
  10. 10Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Recurrence in tuberculosis: Relapse or reinfection? Lancet Infect Dis. 2003; 3(5): 2827. DOI: 10.1016/S1473-3099(03)00607-8
  11. 11McIvor A, Koornhof H, Kana BD. Relapse, re-infection and mixed infections in tuberculosis disease. Pathog Dis. 2017; 75(3). DOI: 10.1093/femspd/ftx020
  12. 12Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414): 55760. DOI: 10.1136/bmj.327.7414.557
  13. 13DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: An update. Contemp Clin Trials. 2007; 28(2): 10514. DOI: 10.1016/j.cct.2006.04.004
  14. 14Alonso FOM, Sabino BD, Guimarães M, Varella RB. Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: Case report. J Med Virol. 2021; 93(2): 6556. DOI: 10.1002/jmv.26432
  15. 15An J, Liao X, Xiao T, et al. Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test. medRxiv. 2020. DOI: 10.1101/2020.03.26.20044222
  16. 16Batisse D, Benech N, Botelho-Nevers E, et al. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? J Infect. 2020; 81(5): 81646. DOI: 10.1016/j.jinf.2020.06.073
  17. 17Bongiovanni M, Basile F. Re-infection by COVID-19: A real threat for the future management of pandemia? Infect Dis. 2020; 52(8): 5812. DOI: 10.1080/23744235.2020.1769177
  18. 18Cao H, Ruan L, Liu J, Liao W. The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge. J Med Virol. 2020. DOI: 10.1002/jmv.26017
  19. 19Chen D, Xu W, Lei Z, et al. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report. Int J Infect Dis. 2020; 93: 2979. DOI: 10.1016/j.ijid.2020.03.003
  20. 20Chen J, Xu X, Hu J, et al. Clinical course and risk factors for recurrence of positive SARS-CoV-2 RNA: A retrospective cohort study from Wuhan, China. Aging. 2020; 12(17): 1667589. DOI: 10.18632/aging.103795
  21. 21Chen Y, Bai W, Liu B, et al. Re-evaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: Report from a designated transfer hospital in Chongqing, China. J Infect Public Heal. 2020; 13(7): 9324. DOI: 10.1016/j.jiph.2020.06.008
  22. 22Duggan NM, Ludy SM, Shannon BC, Reisner AT, Wilcox SR. A case report of possible novel coronavirus 2019 reinfection. Am J Emerg Med. 2021; 39: 256.e13. DOI: 10.1016/j.ajem.2020.06.079
  23. 23Fu W, Chen Q, Wang T. Letter to the Editor: Three cases of redetectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies. J Med Virol. 2020. DOI: 10.1002/jmv.25968
  24. 24Gao G, Zhu Z, Fan L, et al. Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case. Infection. 2020; 15. DOI: 10.1007/s15010-020-01485-6
  25. 25Geling T, Huaizheng G, Ying C, Hua H. Recurrent positive nucleic acid detection in a recovered COVID-19 patient: A case report and literature review. Respir Med Case Rep. 2020; 31: 101152. DOI: 10.1016/j.rmcr.2020.101152
  26. 26He F, Luo Q, Lei M, et al. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: A case report and review. Clin Rheumatol. 2020; 39(9): 280310. DOI: 10.1007/s10067-020-05230-0
  27. 27Hu R, Jiang Z, Gao H, et al. Recurrent positive reverse transcriptase-polymerase chain reaction results for coronavirus disease 2019 in patients discharged from a hospital in China. JAMA Network Open. 2020; 3(5): e2010475. DOI: 10.1001/jamanetworkopen.2020.10475
  28. 28Huang J, Zheng L, Li Z, et al. Recurrence of SARS-CoV-2 PCR positivity in COVID-19 patients: A single center experience and potential implications. medRxiv. 2020.
  29. 29Korea Centers for Disease Control & Prevention. Findings from investigation and analysis of re-positive cases (19 May 2020). 2020. https://www.cdc.go.kr/board/board.es?mid=&bid=0030&act=view&list_no=367267&nPage=1.
  30. 30Li J, Huang DQ, Zou B, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol. 2021; 93(3): 144958. DOI: 10.1002/jmv.26424
  31. 31Li XJ, Zhang ZW, Zong ZY. A case of a readmitted patient who recovered from COVID-19 in Chengdu, China. Crit Care. 2020; 24(1). DOI: 10.1186/s13054-020-02877-8
  32. 32Li Y, Hu Y, Yu Y, et al. Positive result of Sars-Cov-2 in faeces and sputum from discharged patients with COVID-19 in Yiwu, China. J Med Virol. 2020; 92(10): 193847. DOI: 10.1002/jmv.25905
  33. 33Liang C, Cao J, Liu Z, et al. Positive RT-PCR test results after consecutively negative results in patients with COVID-19. Infect Dis. 2020; 52(7): 5179. DOI: 10.1080/23744235.2020.1755447
  34. 34Liu T, Wu S, Zeng G, et al. Recurrent positive SARS-CoV-2: Immune certificate may not be valid. J Med Virol. 2020; 92(11): 23846. DOI: 10.1002/jmv.26074
  35. 35Loconsole D, Passerini F, Palmieri VO, et al. Recurrence of COVID-19 after recovery: A case report from Italy. Infection. 2020; 48(6): 9657. DOI: 10.1007/s15010-020-01444-1
  36. 36Luo A. Positive SARS-Cov-2 test in a woman with COVID-19 at 22 days after hospital discharge: A case report. JTCMS. 2020; 7(4): 4137. DOI: 10.1016/j.jtcms.2020.04.001
  37. 37Mardani M, Nadji SA, Sarhangipor KA, Sharifi-Razavi A, Baziboroun M. COVID-19 infection recurrence presenting with meningoencephalitis. New Microbes New Infect. 2020; 37. DOI: 10.1016/j.nmni.2020.100732
  38. 38Peng J, Wang M, Zhang G, Lu E. Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR. Am J Infect Control. 2020; 48(6): 7256. DOI: 10.1016/j.ajic.2020.03.017
  39. 39Qiao XM, Xu XF, Zi H, et al. Re-positive cases of nucleic acid tests in discharged patients with COVID-19: A follow-up study. Front Med. 2020; 7: 349. DOI: 10.3389/fmed.2020.00349
  40. 40Qu YM, Kang EM, Cong HY. Positive result of Sars-Cov-2 in sputum from a cured patient with COVID-19. Travel Med Infect Dis. 2020; 34: 101619. DOI: 10.1016/j.tmaid.2020.101619
  41. 41Tian M, Long Y, Hong Y, Zhang X, Zha Y. The treatment and follow-up of “recurrence” with discharged COVID-19 patients: Data from Guizhou, China. Environ Microbiol. 2020; 22(8): 358892. DOI: 10.1111/1462-2920.15156
  42. 42Wang P. Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man. J Med Virol. 2021; 93(2): 5924. DOI: 10.1002/jmv.26334
  43. 43Wang X, Xu H, Jiang H, et al. The clinical features and outcomes of discharged coronavirus disease 2019 patients: A prospective cohort study. QJM. 2020; 113(9): 65765. DOI: 10.1093/qjmed/hcaa178
  44. 44Wong J, Koh WC, Momin RN, Alikhan MF, Fadillah N, Naing L. Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam. J Med Virol. 2020; 92(11): 284751. DOI: 10.1002/jmv.26199
  45. 45Xiao AT, Tong YX, Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J Med Virol. 2020; 92(10): 17556. DOI: 10.1002/jmv.25855
  46. 46Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. Euro Surveill. 2020; 25(10): 2000191. DOI: 10.2807/1560-7917.ES.2020.25.10.2000191
  47. 47Ye G, Pan Z, Pan Y, et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020; 80(5): e14e7. DOI: 10.1016/j.jinf.2020.03.001
  48. 48Yuan B, Liu HQ, Yang ZR, et al. Recurrence of positive SARS-CoV-2 viral RNA in recovered COVID-19 patients during medical isolation observation. Sci Rep. 2020; 10(1): 11887. DOI: 10.1038/s41598-020-68782-w
  49. 49Yuan J, Kou S, Liang Y, Zeng J, Pan Y, Liu L. PCR assays turned positive in 25 discharged COVID-19 patients. Clinical Infectious Diseases. An Official Publication of the Infectious Diseases Society of America. 2020.
  50. 50Zhang B, Liu S, Dong Y, et al. Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19). J Infect. 2020; 81(2): e49e52. DOI: 10.1016/j.jinf.2020.04.023
  51. 51Zheng KI, Wang XB, Jin XH, et al. A case series of recurrent viral RNA positivity in recovered COVID-19 Chinese patients. J Gen Intern Med. 2020; 35(7): 22056. DOI: 10.1007/s11606-020-05822-1
  52. 52Zhou X, Zhou J, Zhao J. Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: A case report. BMC Infect Dis. 2020; 20(1): 500. DOI: 10.1186/s12879-020-05231-z
  53. 53Zhu H, Fu L, Jin Y, et al. Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection. J Clin Lab Anal. 2020; 34(7): e23392. DOI: 10.1002/jcla.23392
  54. 54Zou Y, Wang BR, Sun L, et al. The issue of recurrently positive patients who recovered from COVID-19 according to the current discharge criteria: Investigation of patients from multiple medical institutions in Wuhan, China. J Infect Dis. 2020. DOI: 10.1093/infdis/jiaa301
  55. 55Bonifacio LP, Pereira APS, Araujo D, et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? A case report from Brazil. Rev Soc Bras Med Trop. 2020; 53: e20200619. DOI: 10.1590/0037-8682-0619-2020
  56. 56Nebehay S. WHO is investigating reports of recovered COVID patients testing positive again 2020. https://www.reuters.com/article/us-health-coronavirus-who/who-is-investigating-reports-of-recovered-covid-patients-testing-positive-again-idUSKCN21T0F1#:~:text=According%20to%20the%20WHO’s%20guidelines,24%20hours%20apart%2C%20it%20added.
  57. 57European Centers for Disease Prevention and Control. Discharge criteria for confirmed COVID-19 cases - When is it safe to discharge COVID-19 cases from the hospital or end home isolation? 2020. https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-Discharge-criteria.pdf.
  58. 58Arevalo-Rodriguez I, Buitrago-Garcia D, Simancas-Racines D, et al. False-negative results of initial RT-PCR assays for COVID-19: A systematic review. PLoS One. 2020; 15(12): e0242958. DOI: 10.1371/journal.pome.0242958
  59. 59Woloshin S, Patel N, Kesselheim AS. False negative tests for SARS-CoV-2 infection - Challenges and implications. N Engl J Med. 2020; 383(6): e38. DOI: 10.1056/NEJMp2015897
  60. 60Miyamae Y, Hayashi T, Yonezawa H, et al. Duration of viral shedding in asymptomatic or mild cases of novel coronavirus disease 2019 (COVID-19) from a cruise ship: A single-hospital experience in Tokyo, Japan. Inter J Infect Dis. 2020; 97: 2935. DOI: 10.1016/j.ijid.2020.06.020
  61. 61Zhou M, Yu FF, Tan L, et al. Clinical characteristics associated with long-term viral shedding in patients with coronavirus disease 2019. Am J Transl Res. 2020; 12(10): 695464.
  62. 62Wang K, Zhang X, Sun J, et al. Differences of severe acute respiratory syndrome coronavirus 2 shedding duration in sputum and nasopharyngeal swab specimens among adult inpatients with coronavirus disease 2019. Chest. 2020. DOI: 10.1016/j.chest.2020.06.015
  63. 63Jiang X, Luo M, Zou Z, Wang X, Chen C, Qiu J. Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days. J Med Virol. 2020; 92(10): 18079. DOI: 10.1002/jmv.25941
  64. 64Yan-Xin C, Ming-Lin X, Xiao-Hui F, et al. Analysis of false negative results in throat swab nucleic acid test of severe acute resporatory syndrome coronavirus 2. Acad J Second Mil Med Univ. 2020; 41(6): 5925.
  65. 65Alonso FOM, Sabino BD, Guimaraes M, Varella RB. Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: Case report. J Med Virol. 2021; 93(2): 6556. DOI: 10.1002/jmv.26432
  66. 66Oliveira DS, Medeiros NI, Gomes JAS. Immune response in COVID-19: What do we currently know? Microb Pathog. 2020; 148. DOI: 10.1016/j.micpath.2020.104484
  67. 67Lin YC, Cheng CY, Chen CP, Cheng SH, Chang SY, Hsueh PR. A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response. Int J Infect Dis. 2020; 96: 4646. DOI: 10.1016/j.ijid.2020.05.070
  68. 68Chakrabarti SS, Kaur U, Singh A, et al. Of cross-immunity, herd immunity and country-specific plans: Experiences from COVID-19 in India. Aging Dis. 2020; 11(6): 133944. DOI: 10.14336/AD.2020.1104
  69. 69Liu T, Wu S, Zeng G, et al. Recurrent positive SARS-CoV-2: Immune certificate may not be valid. J Med Virol. 2020; 92(11): 23846. DOI: 10.1002/jmv.26074
  70. 70Ji W, Huh K, Kang M, et al. Effect of underlying comorbidities on the infection and severity of COVID-19 in Korea: A nationwide case-control study. J Korean Med Sci. 2020; 35(25): e237. DOI: 10.3346/jkms.2020.35.e237
  71. 71Lyman GH, Kuderer NM. The strengths and limitations of meta-analyses based on aggregate data. BMC Med Res Methodol. 2005; 5: 14. DOI: 10.1186/1471-2288-5-14
  72. 72He S, Zhou K, Hu M, et al. Clinical characteristics of “re-positive” discharged COVID-19 pneumonia patients in Wuhan, China. Sci Rep. 2020; 10(1): 17365. DOI: 10.1038/s41598-020-74284-6
  73. 73Hoang VM, Hoang HH, Khuong QL, La NQ, Tran TTH. Describing the pattern of the COVID-19 epidemic in Vietnam. Glob Health Action. 2020; 13(1). DOI: 10.1080/16549716.2020.1776526
  74. 74Zhang JF, Yan K, Ye HH, Lin J, Zheng JJ, Cai T. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standards for discharge. Int J Infect Dis. 2020; 97: 2124. DOI: 10.1016/j.ijid.2020.03.007
DOI: https://doi.org/10.5334/aogh.3163 | Journal eISSN: 2214-9996
Language: English
Published on: Mar 24, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Tung Hoang, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.